Intrauterine Disorder
Conditions
Keywords
pregnant women, nanoparticles, amniotic fluid
Brief summary
The nanoparticles (NP) are defined as particles whose size is no greater than 100 nanometers. However, their impact on health remains little evaluated. Placental transfer of NP has been proven in many studies in vitro and in vivo in animals, and toxicity in the fetus has been studied in many animals. The investigators seem interesting at first to establish the mineralogical load in the amniotic fluid in humans. The first objective of this study is to determine the mineralogical NP load, quantity and composition, in the amniotic fluid in pregnant women.
Detailed description
The analysis will be done on 100 amniotic fluid samples and 100 blood samples. Particle size analysis will be performed by a technique of dynamic light scattering, which permits the distribution by volume or by number of NP according to their size. Parallel to the different chemical species present in the sample must be measured by atomic emission spectrometry with inductively coupled plasma. The results of this study will be useful for further studies on the fetal toxicity of NP in humans.
Interventions
PROCEDURENanoparticles load
Pregnant women will have a sampling of amniotic fluid to measure load and composition of nanoparticles.
Sponsors
SAINBIOSE
Centre Hospitalier Universitaire de Saint Etienne
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 55 Years
Healthy volunteers
No
Inclusion criteria
* Patient major * Patient to receive an amniocentesis for medical reasons other than study (serum marker of the first quarter with an increased risk of trisomy 21 greater than 1/250, amniodrainage, sonographic sign of call) * Patient who have given their free, informed and signed
Exclusion criteria
* Inability to make withdrawals
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of nanoparticles in amniotic fluid (%) | day 1 | Percentage of each mineralogical Nanoparticle present in the amniotic fluid |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of nanoparticles in blood | day 1 | Percentage of each mineralogical Nanoparticle present in maternal blood |
| Correlation Nanoparticles between blood and amniotic fluid | day 1 | Establish a correlation between the mineralogical NP load in amniotic fluid and maternal blood. |
Countries
France
Outcome results
None listed